COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-10, Vol.34 (10), p.2813-2814
Hauptverfasser:	Breccia, Massimo, Piciocchi, Alfonso, De Stefano, Valerio, Finazzi, Guido, Iurlo, Alessandra, Fazi, Paola, Soddu, Stefano, Martino, Bruno, Palandri, Francesca, Siragusa, Sergio, Albano, Francesco, Passamonti, Francesco, Vignetti, Marco, Vannucchi, Alessandro M.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/2331 692/308/174 Betacoronavirus - pathogenicity Cancer Research Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronavirus Infections - mortality Coronavirus Infections - virology Correspondence COVID-19 Critical Care Medicine Cross-Sectional Studies Disease Progression Hematology Humans Intensive Internal Medicine Italy - epidemiology Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - epidemiology Leukemia, Myelogenous, Chronic, BCR-ABL Positive - mortality Leukemia, Myelogenous, Chronic, BCR-ABL Positive - virology Medicine Medicine & Public Health Myeloproliferative diseases Nitriles Oncology Pandemics Philadelphia Chromosome - drug effects Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Pneumonia, Viral - mortality Pneumonia, Viral - virology Pyrazoles - therapeutic use Pyrimidines SARS-CoV-2 Severity of Illness Index Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!